Having trouble accessing articles? Reset your cache.

Eylea gets expanded label, CHMP recommendation

FDA approved an sBLA from Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) to expand

Read the full 112 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE